Litcius/Paper detail

False-Positive 68Ga–Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient With Breast Cancer

Cihan Gündoğan, Yunus Güzel, Canan Can, Ulaş Alabalık, Halil Kömek

2021Clinical Nuclear Medicine23 citationsDOI

Abstract

ABSTRACT: 68Ga-fibroblast activation protein-specific inhibitor (FAPI)-04 PET/CT was performed in a patient with left lower outer quadrant breast cancer who had 18F-FDG PET/CT imaging. 68Ga-FAPI-04 PET/CT showed higher accumulation of radiotracer in primary tumor and axillary lymph nodes than 18F-FDG PET/CT. In addition, focal increased FAPI uptake was observed in another nodular lesion in the lower inner quadrant in the same breast, which was considered malignant. However, Tru-Cut biopsy of this lesion was reported as benign lymphoid tissue. This case showed that all FAPI accumulation in breast tissue should not be interpreted in favor of malignancy; histopathological confirmation is required.

Topics & Concepts

MedicineFibroblast activation protein, alphaBreast cancerMalignancyQuadrant (abdomen)BiopsyLymphLesionAxillary lymph nodesPathologyLymphatic systemCancerPET-CTRadiologyNuclear medicinePositron emission tomographyInternal medicinePeptidase Inhibition and AnalysisProtease and Inhibitor MechanismsCardiac Structural Anomalies and Repair
False-Positive 68Ga–Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient With Breast Cancer | Litcius